Dextran 40 is a high-molecular glucose polymer, which can increase plasma colloid osmotic pressure, absorb extravascular water and expand blood volume. Because of its small molecular weight and rapid excretion, its expansion effect is not long-lasting, but this drug can cover the surface of red blood cells and increase blood volume. The negative charge on the surface makes it difficult for red blood cells to aggregate, and can depolymerize the aggregated red blood cells, thereby reducing blood viscosity and improving microcirculation. Dextran can also wrap around the surface of platelets and cover the damaged vascular intima, thereby inhibiting the adhesion and aggregation of platelets, thereby preventing thrombus formation. It still has an osmotic diuretic effect.
Dextran 40 is mainly used for various shocks, among which the curative effect on hemorrhagic shock is better than dextran 70, because it can improve microcirculation and tissue perfusion in addition to expanding blood volume, and can also be used for trauma, burns and toxic shock. Early prevention of disseminated intravascular coagulation caused by shock. Thrombotic diseases such as cerebral thrombosis, angina pectoris and myocardial infarction, thromboangiitis obliterans, retinal artery and vein thrombosis, skin ischemic ulcer, etc. Limb replantation and vascular surgery can prevent postoperative thrombosis, improve blood circulation, and increase the success rate of replantation.